Medical Advocates

Efavirenz
(Sustiva/Strocrin)
 
Main Page

New and Noteworthy
Atripla
FDA Alerts/ Label Revisions
Database of ARV Drug Interactions
Journal Data
Conference Data
Guidelines
Perinatal Data
Pediatric Data
ARV Drugs Main Page


 

ARV Drugs Main Page New/Newsworthy Home Page      

This web page is best viewed by using INTERNET EXPLORER
Last Update:  March 13, 2010

 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy
     

March 2010
 

February 2010
 

17th CROI Citations
 
  • POSTER
    2-Year Evolution of Triglycerides and Cholesterol in Thai HIV-1-infected Children Receiving
    First-line NVP or Efavirenz EFV-based Regimen

    S Kanjanavanit, R Hansudewechakul, S Kim, et al

    PDF Poster
         Abstract
  • POSTER
    A One-pill, Once-daily Fixed-dose Combination of Efavirenz, Emtricitabine, and
    Tenofovir Disoproxil Fumarate Regimen Is Associated with Higher Unannounced
    Pill Count Adherence than Non-one-pill, Once-daily Regimens

    D Bangsbe, K Ragland, A Monk, et al 
    1

    PDF Poster
         Abstract
  • POSTER
    Genotypic Resistance at Viral Rebound in Antiretroviral-Naive Subjects Randomized to
    Receive Lopinavir/Ritonavir (LPV/r) or Efavirenz (EFV)-Based Regimens in South Africa -
    A Substudy of the Phidisa II Trial

    J Dlamini, Z H, L Morris,  et al
    PDF Poster
         Abstract
  • POSTER
    Metabolic Profiles and Body Composition Changes in Treatment-Naive HIV-Infected Patients
    Treated with Raltegravir 400 mg Twice-daily vs Efavirenz 600 mg Each bedtime Combination
    Therapy: 96-Week Follow-Up

    E DeJesus, C Cohe, J Lennox,  et al
    PDF Poster     Abstract
  • POSTER
    Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel,
    and Efavirenz

    M Carten, J Kiser, A Kwara, et al
    PDF Poster
         Abstract
  • POSTER
    Pharmacokinetics of Efavirenz Dosed According to the WHO Weight-bands in Children in Uganda

    S Bakeera-Kitaka, E Natukunda, L Kendall, et al
    PDF Poster
         Abstract
  • Pregnancy, Efavirenz, and Birth Outcomes in Johannesburg
    D Westreich, D Rubel, P MacDonald, et al
Journal Citations
 
 

FDA Alerts/Label Revisions
       


ARV Drugs Main Page New/Newsworthy Home Page      

Efavirenz Main Page